---
title: Altasciences vs Protheragen
slug_a: altasciences
slug_b: obesityscientific
site: cro
review_signal_gate: closed
canonical_path: /compare/altasciences/obesityscientific
---

# Altasciences vs Protheragen

Side-by-side profile data from each company listing on this directory.

## Altasciences

- Profile: [/companies/altasciences](/companies/altasciences)

Altasciences — Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.

Services: 22. Modalities: 4. Indications: 12. Locations: 21. Certifications: 3. The strongest documented coverage currently appears in services (22).

### Services

- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Formulation Development
- Stability Testing & Storage

### Modalities

- Small Molecule
- Biologics (Other)
- Cell Therapy
- Gene Therapy

### Indications

- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Women's Health

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Protheragen

- Profile: [/companies/obesityscientific](/companies/obesityscientific)

Protheragen — Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Services: 27. Modalities: 5. Indications: 1. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Cell Therapy
- Gene Therapy
- Peptide

### Indications

- Metabolic

### Phases

- Preclinical (General)
- Phase I
- Discovery
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)